Skip to main content
PRCT
NASDAQ Life Sciences

Q3 Revenue Misses Estimates as Adjusted EBITDA Loss Widens to $9.8M

Tom Rudovsky · Reported by Reuters
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$20.11
Mkt Cap
$1.241B
52W Low
$16.665
52W High
$38.11
52W Position info
21% above low
Off High info
47% below high
Rel. Volume info
2.3× avg
Market data snapshot near publication time

PRCT sits 21% above its 52-week low of $16.665 on elevated volume (2.3× avg).

Summary

Q3 revenue came in at $98.291 million against the $102.6 million IBES estimate, a miss of roughly 4%. The adjusted EBITDA loss of $9.822 million was far wider than the $5.68 million loss analysts expected, and net loss for the quarter was $26.516 million. Full-year guidance points to a 65% gross margin and an adjusted EBITDA loss of $35 million to $30 million, versus the $33.7 million loss consensus. The revenue shortfall combined with the deeper-than-expected cash burn is the key negative — the company is spending more to generate less top line than the Street modeled. This follows the August disclosure that CEO Larry Wood bought $498,315 of stock at $20.85, a purchase made well above today's $20.11 price.

At the time of this announcement, PRCT was trading at $20.11 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $16.67 to $38.11. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

PRCT - Latest Insights

PRCT
Nov 04, 2026, 4:50 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $18.06
Real-time Price: $24.90 info
Change: +$6.84 (+38%) info
Market Cap: $1.421B info
PRCT
Aug 04, 2026, 4:12 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $17.57
Real-time Price: $24.90 info
Change: +$7.33 (+42%) info
Market Cap: $1.421B info
PRCT
Aug 04, 2026, 6:36 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $18.42
Real-time Price: $24.90 info
Change: +$6.48 (+35%) info
Market Cap: $1.421B info
PRCT
Aug 03, 2026, 7:33 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $18.62
Real-time Price: $24.90 info
Change: +$6.28 (+34%) info
Market Cap: $1.421B info
PRCT
May 28, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $26.52
Real-time Price: $24.90 info
Change: -$1.62 (-6%) info
Market Cap: $1.421B info